|
1.
|
|
4 p, 111.4 KB |
SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria
/
Griffin, Morag (Department of Hematology. St James University Hospitals) ;
Eikema, Dirk-Jan (EBMT Statistical Unit) ;
Verheggen, Inge (EBMT Leiden Study Unit) ;
Kulagin, Alexander (Pavlov University) ;
Tjon, Jennifer M-L (Department of Hematology. Leiden University Medical Center) ;
Fattizzo, Bruno (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ;
Ingram, Wendy (Department of Hematology. University Hospital of Wales) ;
Zaidi, Uzma (National Institute of Blood Disease & Bone Marrow Transplantation) ;
Desnica, Lana (Department of Hematology. University Hospital Center Zagreb) ;
Giammarco, Sabrina (Dipartimento di Diagnostica per Immagini. Radioterapia Oncologica ed Ematologia. Fondazione Policlinico Universitario A. Gemelli IRCCS) ;
Drozd-Sokolowska, Joanna (Department of Hematology. Medical University of Warsaw) ;
Xicoy, Blanca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Patriarca, Andrea (AOU Maggiore della Carità (Itàlia)) ;
Loschi, Michael (Cote d'Azur University) ;
Szmigielska-Kaplon, Anna (Department of Hematology. Copernicus Hospital) ;
Beier, F. (RWTH Aachen University) ;
Cignetti, Alessandro (University Division of Hematology) ;
Drexler, Beatrice (University Hospital Basel (Basilea, Suïssa)) ;
Gavriilaki, Eleni (Department of Hematology. George Papanicolaou General Hospital) ;
Lanza, Francesco (Hospital Santa Maria delle Croci) ;
Orvain, Corentin (Centre Hospitalier Universitaire d'Angers) ;
Risitano, Antonio Maria (Department of Hematology. AORN Moscati) ;
de la Camara, Rafael (Hospital Universitario de la Princesa (Madrid)) ;
Peffault de Latour, Régis (Hôpital Saint-Louis)
2024 -  10.3324/haematol.2023.283863
Haematologica, Vol. 109 Núm. 1 (january 2024) , p. 283-286
|
|
|
2.
|
|
13 p, 1.7 MB |
A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation
/
Cremers, Eline M.P. (VU University Medical Centre) ;
de Witte, Theo (Radboud University Medical Centre) ;
de Wreede, Liesbeth C. (Leiden University Medical Center) ;
Eikema, Diderik-Jan (EBMT Statistical Unit Data Office Leiden) ;
Koster, Linda (EBMT Data Office Leiden) ;
van Biezen, Anja (EBMT Data Office Leiden) ;
Finke, Jürgen (University of Freiburg) ;
Socié, Gerard (Hospital St. Louis) ;
Beelen, Dietrich (University Hospital) ;
Maertens, Johan (University Hospitals Gasthuisberg (Leuven, Bélgica)) ;
Nagler, Arnon (Chaim Sheba Medical Center (Israel)) ;
Kobbe, Guido (Heinrich Heine Universitaet) ;
Ziagkos, Dimitris (EBMT Statistical Unit Data Office Leiden) ;
Itälä-Remes, Maija (HUCH Comprehensive Cancer Center) ;
Gedde-Dahl, Tobias (Oslo University Hospital (Oslo, Noruega)) ;
Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Niederwieser, Dietger (University Hospital Leipzig) ;
Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suecia)) ;
Beguin, Yves (University of Liège) ;
Ozkurt, Zubeyde Nur (Gazi University) ;
Anagnostopoulos, Achilles (George Papanicolaou General Hospital (Tessalònia, Grècia)) ;
Jindra, Pavel (Charles University Hospital) ;
Robin, Marie (Hospital St. Louis) ;
Kröger, Nicolaus (University Hospital Eppendorf) ;
Universitat Autònoma de Barcelona
Most myelodysplastic syndromes (MDS)-patients receive multiple red blood cell transfusions (RBCT). Transfusions may cause iron-related toxicity and mortality, influencing outcome after allogeneic HSCT. [...]
2019 - 10.1080/10428194.2019.1594215
Leukemia and Lymphoma, Vol. 60 Núm. 10 (2019) , p. 2404-2414
|
|
|
3.
|
|
8 p, 1.8 MB |
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT) : an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)
/
Saccardi, Riccardo (Careggi University Hospital (Florència, Itàlia)) ;
Putter, Hein (Leiden University Medical Center) ;
Eikema, Dirk-Jan (EBMT Statistical Unit Leiden) ;
Busto, María Paula (EBMT Registry) ;
McGrath, Eoin (ICCBBA (Barcelona, Espanya)) ;
Middelkoop, Bas (European Society for Blood and Marrow Transplantation-EBMT Registry) ;
Adams, Gillian (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Atlija, Marina (European Society for Blood and Marrow Transplantation-EBMT Registry) ;
Ayuk, Francis (University Medical Center Hamburg) ;
Baldomero, Helen (University Hospital Basel (Basilea, Suïssa)) ;
Beguin, Yves (CHU of Liège and University of Liège) ;
de la Camara, Rafael (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Cedillo Cedillo, Angel (Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular) ;
Balari, Anna María Sureda (Hospital Universitari de Bellvitge) ;
Chabannon, Christian (Institut Paoli-Calmettes Comprehensive Cancer Centre) ;
Corbacioglu, Selim (University Children's Hospital Regensburg) ;
Dolstra, Harry (Radboud University Medical Center) ;
Duarte, Rafael (Universidad Autónoma de Madrid) ;
Duléry, Rémy (Sorbonne Université) ;
Greco, Raffaella (Autoimmune Diseases Working Party (Barcelona, Espanya)) ;
Gusi, Andreu (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Hamad, Nada (University of Notre Dame Australia) ;
Kenyon, Michelle (King's College Hospital NHS Foundation Trust) ;
Kroeger, Nicolaus (University Medical Center Hamburg) ;
Labopin, Myriam (European Society for Blood and Marrow Transplantation-EBMT Paris Study Office) ;
Lee, Julia (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ;
Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Manson, Lynn (Edinburgh & SE Scotland Clinical Transfusion Centre Patient Services (Regne Unit)) ;
Mensil, Florence (Agence de la Biomédecine) ;
Milpied, Noel (Centre Hospitalier Universitaire Bordeaux) ;
Mohty, Mohamad (Sorbonne University) ;
Oldani, Elena (Italian National BMT Registry) ;
Orchard, Kim (University Hospital Southampton NHS) ;
Passweg, Jakob (University Hospital Basel (Basilea, Suïssa)) ;
Pearce, Rachel (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ;
de Latour, Régis Peffault (BMT unit Paris Cité University) ;
Poirel, Hélène A. (Belgian Transplant Registry) ;
Rintala, Tuula (King's College Hospital NHS Foundation Trust) ;
Rizzo, J. Douglas (CIBMTR, Medical College of Wisconsin) ;
Ruggeri, Annalisa (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ;
Sanchez-Martinez, Carla (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Sanchez-Guijo, Fermin (CIC-University of Salamanca) ;
Sánchez-Ortega, Isabel (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Trnková, Marie (Czech registry Czech Republic) ;
Valcárcel, David (Vall d'Hebron Institut d'Oncologia) ;
Wilcox, Leonie (Australasian Bone Marrow Transplant Recipient Registry) ;
de Wreede, Liesbeth C. (Leiden University Medical Center) ;
Snowden, John A. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
Universitat Autònoma de Barcelona
From 2016 EBMT and JACIE developed an international risk-adapted benchmarking program of haematopoietic stem cell transplant (HSCT) outcome to provide individual EBMT Centers with a means of quality-assuring the HSCT process and meeting FACT-JACIE accreditation requirements relating to 1-year survival outcomes. [...]
2023 - 10.1038/s41409-023-01924-6
Bone marrow transplantation, march 2023, p. 1-8
|
|
|
4.
|
|
8 p, 732.8 KB |
Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation
/
Gagelmann, N. (University Medical Center Hamburg-Eppendorf) ;
Eikema, D. J. (EBMT Statistics) ;
Stelljes, M. (University of Münster) ;
Beelen, D. (University Hospital Essen (Alemanya)) ;
de Wreede, Liesbeth C (EBMT Statistics) ;
Mufti, G. (GKT School of Medicine) ;
Knelange, N. S. (EBMT Data Office) ;
Niederwieser, D. (University Hospital Leipzig) ;
Friis, L. S. (University of Copenhagen) ;
Ehninger, Gerhard (Universitätsklinikum Dresden) ;
Nagler, Arnon (Chaim Sheba Medical Center (Israel)) ;
Yakoub-Agha, Ibrahim (Université Lille2) ;
Meijer, E. (Amsterdam UMC. University Medical Center) ;
Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Maertens, Johan (University Hospitals Gasthuisberg (Leuven, Bélgica)) ;
Kanz, L. (Universität Tübingen) ;
Lopez-Corral, L. (Hospital Clínico Universitario (Salamanca)) ;
Brecht, A. (Deutsche Klinik für Diagnostik) ;
Craddock, Charles (Centre for Clinical Haematology) ;
Finke, J. (University of Freiburg) ;
Cornelissen, J. J. (Erasmus MC Cancer Institute. Erasmus University Medical Center) ;
Bernasconi, P. (Fondazione IRCCS Policlinico San Matteo) ;
Chevallier, Patrice (CHU Nantes) ;
Sierra, Jorge (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Robin, M. (Hopital St. Louis) ;
Kroeger, Nicolaus (University Medical Center Hamburg-Eppendorf) ;
Universitat Autònoma de Barcelona
The aim of this study was to develop and validate a clinical and transplant-specific prognostic score using data from a large cohort of patients with myelodysplastic syndromes reported to the European Society for Blood and Marrow Transplantation registry. [...]
2019 - 10.3324/haematol.2018.200808
Haematologica, Vol. 104 Núm. 5 (30 2019) , p. 929-936
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
